Recombinant human thrombopoietin is a full-length glycosylated cytokine produced by Chinese hamster ovary cells and is used to promote the generation of megakaryocytes and platelets. This drug is used in...
- Mechanism
- Curator reviewed · 2 references
Recombinant human thrombopoietin has similar biological functions as endogenous thrombopoietin. It activates the thrombopoietin receptor MPL. This therapy has potential roles in hematopoietic stem and progenitor cell regeneration and is currently being investigated against relapsed immune thrombocytopenia, hematopoietic injury, and acute severe thrombocytopenia in sepsis.
- Also known as
- rhTPO · rHuTPO
- Code names
- Recombinant Human Thrombopoietin
Resolves to
What you can answer from here — as of July 08, 2026
Which drugs share a target with Recombinant Human Thrombopoietin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account